AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status
Rui Ma(First Hospital of China Medical University), Yunpeng Liu(Capital Medical University)
Cited by 29
Related Papers
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis
|BMC Cancer|2011|136
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
|BMC Cancer|2018|86